PsiOxus secures about $34M for clinical development of oncolytic virus
PsiOxus Therapeutics raised about $34 million in a funding round led by Imperial Innovations. -More-
Original Article: PsiOxus secures about $34M for clinical development of oncolytic virus
NEXT ARTICLE